Amphotericin B toxicity as related to the formation of oxidatively modified low-density lipoproteins.

The effect of amphotericin B on the oxidation and degradation of low- and high-density lipoproteins was investigated by UV-vis spectroscopy, electron microscopy, electrophoresis, and size-exclusion chromatography. Two formulations of the drug were used: the commercial Fungizone and a new, less toxic, liposomal formulation, AmBisome. It was shown that Fungizone strongly enhanced the oxidative deformation of low-density lipoprotein structure while AmBisome did not bind to this lipoprotein fraction and did not affect its oxidation. It was shown that amphotericin B contained in Fungizone extracted cholesterol from low-density lipoproteins which sensitized them to oxidation. Both formulations of amphotericin B studied here did not bind to high-density lipoprotein and did not affect the process of its oxidation.

[1]  J. Strang,et al.  Liposomal amphotericin B (AmBisome) in the treatment of fungal infections in neutropenic patients. , 1991, The Journal of antimicrobial chemotherapy.

[2]  H. Esterbauer,et al.  The role of lipid peroxidation and antioxidants in oxidative modification of LDL. , 1992, Free radical biology & medicine.

[3]  J. Guyton,et al.  Cytotoxicity of oxidized LDL to porcine aortic smooth muscle cells is associated with the oxysterols 7-ketocholesterol and 7-hydroxycholesterol. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[4]  H. Hoff,et al.  Aggregation as well as chemical modification of LDL during oxidation is responsible for poor processing in macrophages. , 1993, Journal of lipid research.

[5]  T. Andreoli.  THE STRUCTURE AND FUNCTION OF AMPHOTERICIN B‐CHOLESTEROL PORES IN LIPID BILAYER MEMBRANES * , 1974, Annals of the New York Academy of Sciences.

[6]  G. Lopez-Berestein,et al.  Roles of liposome composition and temperature in distribution of amphotericin B in serum lipoproteins , 1993, Antimicrobial Agents and Chemotherapy.

[7]  J. Bolard,et al.  Differences in the interaction of the polyene antibiotic amphotericin B with cholesterol- or ergosterol-containing phospholipid vesicles. A circular dichroism and permeability study. , 1983, Biochemistry.

[8]  G. Medoff,et al.  Effects of elevation of serum cholesterol and administration of amphotericin B complexed to lipoproteins on amphotericin B-induced toxicity in rabbits , 1985, Antimicrobial Agents and Chemotherapy.

[9]  Ming Liu,et al.  Disparate effects of oxidation on plasma acyltransferase activities: inhibition of cholesterol esterification but stimulation of transesterification of oxidized phospholipids. , 1996, Biochimica et biophysica acta.

[10]  G. Medoff,et al.  Amphotericin B-induced oxidative damage and killing of Candida albicans. , 1986, The Journal of infectious diseases.

[11]  J. Barwicz,et al.  Inhibition of the interaction between lipoproteins and amphotericin B by some delivery systems. , 1991, Biochemical and Biophysical Research Communications - BBRC.

[12]  D. Schlessinger,et al.  Interaction of plasma proteins and lipoproteins with amphotericin B. , 1984, The Journal of infectious diseases.

[13]  G. Lopez-Berestein,et al.  Decreased toxicity of liposomal amphotericin B due to association of amphotericin B with high-density lipoproteins: role of lipid transfer protein. , 1994, Journal of pharmaceutical sciences.

[14]  R. Stocker,et al.  Oxidation of low-density lipoprotein by hypochlorite causes aggregation that is mediated by modification of lysine residues rather than lipid oxidation. , 1994, The Biochemical journal.

[15]  F. Ursini,et al.  Analysis of plasma cholesterol oxidation products using gas- and high-performance liquid chromatography/mass spectrometry. , 1994, Free radical biology & medicine.

[16]  D. Kramsch,et al.  Biochemical and cytotoxic characteristics of an in vivo circulating oxidized low density lipoprotein (LDL-). , 1994, Journal of lipid research.

[17]  T. Kodama,et al.  Oxidation-induced aggregation of rabbit low-density lipoprotein by azo initiator. , 1994, Archives of biochemistry and biophysics.

[18]  G. Rebell.  Effect of lipoproteins on hemolytic and antifungal activity of amphotericin B and other polyene antibiotics. , 1966, Antimicrobial agents and chemotherapy.

[19]  I. Ortega‐Blake,et al.  A microscopic electrostatic model for the amphotericin B channel. , 1991, Biochimica et biophysica acta.

[20]  F. Hatch.  Practical methods for plasma lipoprotein analysis. , 1968, Advances in lipid research.

[21]  T. E. Whitaker,et al.  Oxidation of low density lipoprotein leads to particle aggregation and altered macrophage recognition. , 1992, The Journal of biological chemistry.

[22]  S. Schreier,et al.  Effect of aggregation on the kinetics of autoxidation of the polyene antibiotic amphotericin B. , 1993, Journal of pharmaceutical sciences.

[23]  R. P. Noble.  Electrophoretic separation of plasma lipoproteins in agarose gel. , 1968, Journal of lipid research.